Meeting Coverage

Psych Congress

Psychiatry & Behavioral Health Learning Network

PCPs Often First Stop for Managing Newly Diagnosed Depression

First-year care trajectories looked different than those seeing psychiatrists

Psych Congress over a photo of Music City Center in Nashville, Tennessee.

Latest Psych Congress Meeting Coverage

Safety Profile Sways Physicians on Use of LAIs for Schizophrenia

Nearly half of hesitant prescribers cited safety and tolerability as their top concern

September 12, 2023
Patients With Narcolepsy Face Mood and Pain Disorders

Comorbidities may complicate treatment and diagnosis

September 11, 2023
Long-Acting Schizophrenia Tx Shows Long-Term Safety With Limited Relapses

Most patients on twice-a-year doses of paliperidone palmitate remained relapse-free over 3 years

September 11, 2023
Heart Risks Much Higher for Patients With Rare Sleep Disorder

Treatment should be prescribed with cardiovascular risks in mind, says researcher

September 11, 2023
Spravato Safety Holds Up Long-Term for Treatment-Resistant Depression

Most adverse events dissipated after second or third treatment with intranasal esketamine

September 11, 2023
Physician Assistants Also Feel Post-Pandemic Burnout

Symptoms had some PAs saying they intended to leave their clinical posts sooner rather than later

September 11, 2023
Delayed-Release ADHD Therapy Slightly Mitigates Slowed Growth in Kids

Youth on Jornay PM saw significantly higher weight trajectories

September 9, 2023
How Durable Are Responses to Novel Antidepressant Zuranolone in MDD?

SHORELINE trial found reduced depression symptoms even in those exiting study early

September 23, 2022
Depression Treatment Failure Burdens Patients' Life and Wallets

Even mild cases tied to reduced quality of life and high medical costs, survey showed

September 21, 2022
Comorbidities May Stall Diagnosis of PTSD in the General Population

Analysis shows that many patients are treated for symptoms of the disorder before diagnosis

September 21, 2022
Low-Dose Cariprazine for MDD Tied to Anxiety Reduction

Potential add-on therapy also improved most individual depressive symptoms on MADRS

September 20, 2022
No Weird Dreams for Insomnia Patients Taking Lemborexant

Even at 10 mg, the sleep aid resulted in few abnormal dreams or nightmares

September 20, 2022
Trazodone Commonly Used Off-Label for Insomnia

Not much data to support efficacy or safety "as a surrogate hypnotic medication," researcher says

September 20, 2022
Rexulti Calms Alzheimer's Dementia-Related Agitation

But atypical antipsychotic disappoints in borderline personality disorder

September 19, 2022